PROTAC BET-binding moiety 2

Target: This ligand targets BET-family bromodomains, including BRD2, BRD3, BRD4, and BRDT in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for BET-family bromodomains, including BRD2, BRD3, BRD4, and BRDT. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings BET-family bromodomains into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• BET-Binding PROTAC Recruitment: This BET-binding moiety is designed to engage bromodomain-containing targets commonly implicated in transcriptional regulation. In PROTAC constructs, it serves as the target-recognition element to position an E3 ligase recruiter for proximity-driven ubiquitination, enabling degradation studies that probe BET protein dependence and downstream transcriptional consequences.

• Transcriptional Dependency Mapping: Use this ligand within PROTACs to systematically evaluate how BET family members contribute to gene expression programs. By comparing degradation efficiencies across BET isoforms and cellular contexts, researchers can link selective protein loss to changes in chromatin-associated transcription, facilitating mechanism-driven target validation.

• Selective BET Isoform Degradation: Incorporate the BET-binding moiety into PROTAC designs to test isoform-selective degradation strategies. Researchers can vary linker length and E3 ligase choice to tune ternary complex formation, then quantify degradation kinetics and functional readouts to determine whether specific BET bromodomains are preferentially degraded.

• Chromatin-Linked Functional Studies: This BET-binding element can be used in PROTACs to interrogate chromatin-associated functions mediated by bromodomains. Targeted degradation allows researchers to distinguish effects of catalytic or binding inhibition from those of complete protein removal, supporting rigorous assessment of epigenetic regulation and phenotype causality.

• Mechanistic Ternary Complex Optimization: Employ the moiety as the BET-recognition module while optimizing PROTAC parameters that govern ternary complex stability. Systematic variation of linker chemistry and attachment sites can improve productive ubiquitination, enabling studies that correlate binding geometry with degradation potency and specificity.

PROTAC BET-binding moiety 2 is a BET bromodomain target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of PROTAC BET-binding moiety 2 is characterized by carboxylic acid or carboxylate handle; halogenated aryl/heteroaryl ring system; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.